Transcranial Direct Current Stimulation for Traumatic Brain Injury
Trial Summary
What is the purpose of this trial?
The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., pre-supplementary motor area) thought to aid in memory will improve verbal retrieval in civilian (non-military, non-veteran) participants with histories of traumatic brain injuries. The primary outcome measures are neuropsychological assessments of verbal retrieval, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures. Additionally, the study will examine the degree to which baseline assessments of cognition, concussion history, structural brain imaging, and EEG predict responses to treatment over time, both on assessments administered within the intervention period and at follow-up.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment High Definition Transcranial Direct Current Stimulation for Traumatic Brain Injury?
Is transcranial direct current stimulation (tDCS) safe for humans?
How is High Definition Transcranial Direct Current Stimulation (HD-tDCS) different from other treatments for traumatic brain injury?
High Definition Transcranial Direct Current Stimulation (HD-tDCS) is unique because it uses targeted electrical currents to improve cognitive function in traumatic brain injury patients, even those with skull defects. Unlike traditional treatments, it is non-invasive and focuses on enhancing brain activity rather than using medication.1231011
Research Team
John Hart, MD
Principal Investigator
The University of Texas at Dallas
Eligibility Criteria
This trial is for civilian adults with a history of traumatic brain injury who struggle to find words (anomia). They should not be military or veterans. Participants must be able to undergo neuropsychological assessments and EEG measures, and have no other conditions that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either active or sham transcranial direct current stimulation (tDCS) for 20 minutes over 10 sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 2-months post-treatment
Second Treatment
Participants are re-assigned to the opposite treatment condition (active or sham) for another 20 minutes over 10 sessions
Second Follow-up
Participants are monitored again for safety and effectiveness after the second treatment, with assessments at 2-months post-treatment
Treatment Details
Interventions
- High Definition Transcranial Direct Current Stimulation (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas at Dallas
Lead Sponsor
Dr. Richard Benson
The University of Texas at Dallas
Chief Executive Officer since 2016
PhD in Molecular and Cell Biology from the University of Texas at Dallas
Dr. Patrizia Cavazzoni
The University of Texas at Dallas
Chief Medical Officer
MD from Harvard Medical School
University of Texas Southwestern Medical Center
Collaborator
Daniel K. Podolsky
University of Texas Southwestern Medical Center
Chief Executive Officer since 2008
MD from Harvard Medical School
Robert L. Bass
University of Texas Southwestern Medical Center
Chief Medical Officer since 2019
MD from University of Texas Southwestern Medical School